The distributions of baseline characteristics did not differ between obese and non-obese diabetics, except for those of age, duration of DM, and the incidence of CKD and insulin use which were significantly higher in non-obese DM patients, while obese DM patients had higher incidence of dyslipidemia and higher LVEF after AMI (Table 1). The gene discussed is INS; the disease is metabolic syndrome.